Ligand validation:8IRD

HTG: heptyl 1-thio-beta-D-glucopyranoside

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8IRD_HTG_b_625	72%	36%	0.106	0.929	1.07	1.52	2	4	0	0	100%	1
8IRD_HTG_B_623	67%	40%	0.117	0.925	1.06	1.34	2	3	0	0	100%	1
8IRD_HTG_o_301	51%	34%	0.146	0.899	1.11	1.59	2	5	0	0	100%	1
8IRD_HTG_b_622	36%	26%	0.173	0.865	1.18	1.94	2	7	0	0	100%	1
8IRD_HTG_B_621	21%	44%	0.239	0.851	0.84	1.37	1	1	0	0	100%	1
8IRD_HTG_c_522	19%	37%	0.272	0.87	0.93	1.6	1	2	0	0	100%	1
8IRD_HTG_D_411	10%	37%	0.263	0.797	1.04	1.52	1	1	0	0	84%	0.8421
8IRD_HTG_C_522	8%	44%	0.341	0.812	0.85	1.36	1	2	0	0	100%	1
8IRD_HTG_d_411	8%	37%	0.31	0.804	0.95	1.59	1	1	0	0	84%	0.8421
8IRD_HTG_V_202	5%	58%	0.426	0.925	0.32	1.25	-	1	0	0	58%	0.5789
8IRD_HTG_b_623	1%	29%	0.504	0.726	1.04	1.94	1	3	0	0	100%	1
5V2C_HTG_O_303	94%	35%	0.072	0.972	1.58	1.07	2	2	0	0	100%	1
3WU2_HTG_O_303	89%	38%	0.092	0.971	1.17	1.32	2	1	0	0	100%	1
8IR7_HTG_b_625	81%	38%	0.086	0.939	0.97	1.5	2	3	0	0	100%	1
8IR6_HTG_b_625	81%	37%	0.088	0.941	1.07	1.48	2	4	0	0	100%	1
8IRA_HTG_B_625	81%	46%	0.097	0.95	0.97	1.12	2	2	0	0	100%	1
8IR9_HTG_B_623	81%	46%	0.098	0.95	0.99	1.13	2	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.